Three Clicks From Ozempic. Zero Real Support. The HR Imperative Behind the GLP1 Boom | Road2Wellbeing

GLP-1s are already in your workforce.


One in eight American adults has now used a GLP-1. Most accessed it through a telehealth form with no clinical guardrails and no lifestyle support. This drug suppresses appetite without building the habits that make results last. Without employer-side infrastructure, you’re looking at muscle loss, nutrient deficiencies, and a yo-yo cycle that drives future health claims. The wellness side is where the gaps get filled.

What we discuss

• Why GLP-1s have reached mainstream scale and what the public conversation is missing
• The clinical risks nobody is talking about: muscle loss, nutrient deficiencies, no guardrails
• What the drug does to the body beyond the number on the scale
• Why lifestyle habits have to be built alongside the medication, not after
• What lasting support actually looks like: movement, nutrition, behavior change
• Why HR leaders should care and what they can do about it
• The business case: today’s deficiencies become tomorrow’s health claims
• How to actually start a GLP-1 journey the right way